Stay updated on Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    No substantive content changes detected; the page only updates its revision tag from v3.0.0 to v3.0.2.
    Difference
    0.1%
    Check dated 2025-09-13T15:59:05.000Z thumbnail image
  2. Check
    16 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on various medical compounds and diseases, particularly related to plasma cell myeloma. Notably, several previous entries related to specific drugs and agents have been removed.
    Difference
    4%
    Check dated 2025-08-30T11:26:37.000Z thumbnail image
  3. Check
    24 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:27:36.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-08T23:49:13.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    0.8%
    Check dated 2025-08-01T19:16:14.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version, changing from Revision v2.16.6 to v2.16.8, and it now includes information about the HHS Vulnerability Disclosure.
    Difference
    0.2%
    Check dated 2025-07-25T14:31:51.000Z thumbnail image

Stay in the know with updates to Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab, Ixazomib, Dexamethasone in Relapsed Myeloma Clinical Trial page.